| scholarly article | Q13442814 |
| P50 | author | Keith Norris | Q59817482 |
| P2093 | author name string | Deyu Pan | |
| Magda Shaheen | |||
| Theodore C Friedman | |||
| Juan Ortega | |||
| Tripathi B Rajavashisth | |||
| Satyesh K Sinha | |||
| P2860 | cites work | Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 |
| Diet, lifestyle, and the risk of type 2 diabetes mellitus in women | Q29614196 | ||
| Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor | Q33556725 | ||
| Therapeutic aspects of cannabis and cannabinoids | Q34130996 | ||
| Health care use by frequent marijuana smokers who do not smoke tobacco | Q34210167 | ||
| Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. | Q34409573 | ||
| Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro | Q34574285 | ||
| Obesity and cannabis use: results from 2 representative national surveys | Q34631834 | ||
| Role of urine toxicology testing in the management of chronic opioid therapy | Q35024285 | ||
| Self-report and biochemical measures of alcohol consumption | Q35675669 | ||
| Endocannabinoids in neuroimmunology and stress | Q36352202 | ||
| Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption | Q36431803 | ||
| Cannabidiol arrests onset of autoimmune diabetes in NOD mice | Q36501954 | ||
| Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. | Q40293803 | ||
| Dietary intake and nutritional status of US adult marijuana users: results from the Third National Health and Nutrition Examination Survey. | Q40701375 | ||
| Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey | Q45161589 | ||
| Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). | Q46101257 | ||
| Patterns of alcohol consumption and the metabolic syndrome. | Q46482842 | ||
| Inflammatory markers and risk of developing type 2 diabetes in women | Q48028389 | ||
| Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. | Q55041970 | ||
| Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study | Q60209721 | ||
| Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures | Q72843738 | ||
| Should patients with diabetes drink to their health? | Q78049163 | ||
| New insights into COX-2 biology and inhibition | Q81683819 | ||
| P921 | main subject | US National Health and Nutrition Examination Survey | Q1967281 |
| P304 | page(s) | e000494 | |
| P577 | publication date | 2012-02-24 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. | |
| P478 | volume | 2 |
| Q92772434 | Alcohol and illicit drug use in people with diabetes |
| Q91860838 | Allostatic load and the cannabinoid system: implications for the treatment of physiological abnormalities in post-traumatic stress disorder (PTSD) |
| Q37184653 | Association between adolescent substance use and obesity in young adulthood: a group-based dual trajectory analysis |
| Q37075261 | Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users |
| Q47649773 | Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review |
| Q35751830 | Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model |
| Q93167544 | Bidirectional Longitudinal Associations Between Cannabis Use and Body Mass Index Among Adolescents |
| Q33931558 | C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. |
| Q27318021 | Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples. |
| Q41207222 | Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). |
| Q37397064 | Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women |
| Q27312420 | Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010. |
| Q40715158 | Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. |
| Q41627562 | Cannabis use in relation to obesity and insulin resistance in the Inuit population |
| Q33602403 | Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. |
| Q47804552 | Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly |
| Q36101442 | Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. |
| Q41923080 | Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH). |
| Q97652144 | Dietary quality differs among cannabis use groups: data from the National Health and Nutrition Examination Survey 2005-16 |
| Q89790783 | Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study |
| Q37710989 | Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk |
| Q28078897 | Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes |
| Q46480886 | Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States. |
| Q40632632 | Invited Commentary: The Association Between Marijuana Use and Male Reproductive Health |
| Q92750122 | Is marijuana use associated with lower inflammation? Results from waves III and IV of the national longitudinal study of adolescent to adult health |
| Q92753123 | Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome |
| Q99408001 | Lifetime Average Cannabis Use in Relation to Hypertriglyceridemic Waist Phenotype in U.S. Adults: A Population-Based Cross-Sectional Study |
| Q35911477 | METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS. |
| Q30244481 | Marijuana Use and Type 2 Diabetes Mellitus: a Review |
| Q57155571 | Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis |
| Q90039496 | Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies |
| Q36244815 | Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q64938454 | Marijuana's Influence on Pain Scores, Initial Weight Loss, and Other Bariatric Surgical Outcomes. |
| Q37022702 | Metabolic effects of chronic cannabis smoking |
| Q39930298 | Metabolic syndrome in people with a psychotic illness: is cannabis protective? |
| Q36933683 | Modulating the endocannabinoid system in human health and disease--successes and failures |
| Q37094615 | Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States |
| Q60937774 | Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users |
Search more.